Exclusive: A male contraceptive may prevent 99% of pregnancies. Now it’s up to a small biotech to finish testing it

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Annual General Meeting resolves dividend distribution of EUR 0.88 per share – Biotech Investments

EQS-News: Dermapharm Holding SE / Key word(s): AGM/EGM Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share 27.06.2024 / 18:15

June 28, 2024

Pfizer to further decrease stake in consumer health company Haleon

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 1, 2024

Gilead’s Biktarvy receives FDA expanded approval for HIV

Share this article Gilead’s Biktarvy offers the convenience of once-daily dosing and has a high barrier to resistance with limited drug interaction potential. Credit: Andreas

February 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.